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Some mutations of protein residues matter more than others, and these are often conserved evolutionarily.
The explosion of deep sequencing and genotyping increasingly requires the distinction between effect and
neutral variants. The simplest approach predicts all mutations of conserved residues to have an effect;
however, this works poorly, at best. Many computational tools that are optimized to predict the impact of point
mutations provide more detail. Here, we expand the perspective from the view of single variants to the level of
sketching the entire mutability landscape. This landscape is defined by the impact of substituting every
residue at each position in a protein by each of the 19 non-native amino acids. We review some of the powerful
conclusions about protein function, stability and their robustness to mutation that can be drawn from such an
analysis. Large-scale experimental and computational mutagenesis experiments are increasingly furthering
our understanding of protein function and of the genotype–phenotype associations. We also discuss how
these can be used to improve predictions of protein function and pathogenicity of missense variants.
© 2013 The Authors. Published by Elsevier Ltd. Open access under CC BY license.Introduction
Lewis Carroll—Through the Looking Glass:
“Why, sometimes I've believed as many as six
impossible things before breakfast.”Understanding Genetic Diversity—A
Central Challenge for Deep Sequencing
Elucidating which human genetic variations have
which phenotypic effect and how the variation
impacts disease is one of the major scientific
challenges in the 21st century. While the vast majority
of genetic variants are hypothesized to be neutral [1],
that is, are assumed not to contribute to any
phenotype, the relative percentage of neutral, near-
neutral [2] and non-neutral variants remains unclear.uthors. Published by Elsevier Ltd. Open access uMost likely, the precise ratios heavily depend on the
particular protein under investigation (e.g., the human
immunodeficiency virus gp120 is likely to be much
more robust against mutation than p53 simply
because many of the p53 residues are involved in
binding and therefore “vulnerable” to mutation). A key
aspect in the development of strategies for diagnosis
and treatment of genetic diseases is to further our
understanding of the underlying mechanisms that link
genotypes and phenotypes.
Sequence variants such as single nucleotide poly-
morphisms (SNPs) are the most prevalent form of
human genetic variation [3]. It has been estimated that
more than 11 million SNPs will be observed among
people; 7 million of these are frequent (common
variants), that is, occur with a minor allele frequency
above 5%, while the remaining (minor allele frequen-
cy, b5%) are considered as rare [4]. Many of both rare
and common variants may be instrumental in defining
individual's differences [5–7]. Increasingly, however,J. Mol. Biol. (2013) 425, 3937–3948nder CC BY license.
3938 Perspective: The Protein Mutability Landscaperesearchers begin to suspect that every possible point
mutation might ultimately be observed.
For medical biology, non-synonymous SNPs
(nsSNPs) or missense variants that change the
amino acid sequence of the protein are particularly
interesting. These variants are more likely to affect
function than synonymous SNPs. Single-amino-acid
variants can change the resulting phenotype, forFig. 1 (legend oexample, by altering protein function directly or
indirectly by impacting structure and/or binding.
Such changes can lead to pathogenic phenotypes
[8]. Recent studies suggest that every pair of
individuals differs by almost one amino acid variant
in each protein while individuals have about 1.2–1.7
variants (nsSNPs) that are novel with respect to both
parents, that is, not observed in either parent [7].n next page)
3939Perspective: The Protein Mutability LandscapeKnowing how these changes affect function can
give, for instance, insight into a child's disease
predisposition.
GWAS (genome-wide association studies) has
evolved as the most widely used approach relating
human genetic variation to phenotypic diversity [9].
Results of these studies greatly increased our
understanding of molecular pathways underlying
specific human diseases. Most common SNPs
have been assessed for statistical associations with
many complex traits and common diseases. Howev-
er, for the vast majority of complex trait associations,
the underlyingmechanisms remain unknown, and for
many of the known common SNPs related to
complex disease phenotypes, GWAS misses the
known associations [10]. Rare variants are missed
due to limited numbers [4,11]. The hope is that deep
sequencing will address some of these issues by
revealing variations between the full sequences.Mutability Landscapes May Be THE Key
to Understanding Diversity
Meanwhile, a different approach toward under-
standing the genotype–phenotype association is to
study functionally important regions, robustness and
evolvability of proteins by investigating the mutability
landscape. Themutability landscape of, for example,
protein function, can be defined as the effect of all
possible point mutations/variants upon protein func-
tion, that is, of substituting the native amino acid at
each residue position against all 19 non-native
amino acids, one at a time (Fig. 1 [20,21]). Studying
such a landscape may help us a lot in understanding
protein function and evolution.
In this review, we exclusively focus on the effects
of varying the protein sequence by single-amino-a-
cid substitutions (SAASs). In order to avoid obscur-
ing acronyms, we will simply use the term variant as
synonym for SAAS. We review comprehensive
mutagenesis in which each position in a protein isFig. 1. Mutability landscape of a protein. The top line
(transmembrane helices) of the adrenergic receptor (ADRB2_
the high-resolution structure PDB ID: 3PDS [13] using DSSP [1
shows the predictions for the effects of all 19 non-native varian
stronger the predicted neutrality, the greener). (c) Zoom of the
relative positions of binding sites (D113 and T118) and prop
functional effect of variants for the 3D structure (PDB ID: 2RH1
shown as blue spheres. Shown are the average scores [SNAP
effect (+100)] over amino acids that would be considered a
captured in the PHAT substitution matrix [16] for transmembra
residues. Red depicts high average scores (score N 60), oran
depicts low scores (20 b score b 40) and gray marks sites with
(e) The 3D structure (PDB ID: 3PDS [13]) with a bound agonis
overall predicted effect and are under strong evolutionary cons
two binding sites.changed and complete mutagenesis in which each
position is replaced by every non-native amino acid.
However, we largely discard effects of varying
multiple residues at the same time. Obviously,
even such a reduced version of the protein mutability
landscape already carries very important information
about protein function. We attempt to sketch how this
landscape brings about new challenges and new
possibilities. In fact, we have to learn to understand
what we see in this new looking glass.Most Variant Effects Predicted Correctly
In Silico
Several computational methods predict the effect
of variants (SAAS or nsSNPs). Some predict the
effect on protein function {e.g., sorting intolerant from
tolerant (SIFT) [22,23] or screening for non-accep-
table polymorphisms (SNAP) [24,25]}, others predict
the effect with respect to their pathogenicity (e.g.,
MutPred [26], SNPs&GO [27], Mutation Assesor [28]
or MutationTaster [29]) and others yet predict the
effect on protein structure directly [30] or cannot be
easily fit into these categories (e.g., PolyPhen-2 [31]
or PON-P [32]). These methods use a diverse
spectrum of input features, typically combining
evolutionary information with biophysical features
and experimental information about protein structure
and function where available. There are several
outstanding reviews on the prediction of functional
effects [33–35], and the community puts great effort
into assessing such predictions. For instance, CAGI
(Critical Assessment of Genome Interpretation)
aspires to assessing method performance in pre-
dicting phenotypic impacts of genomic variation [36].
More formal studies assess predictors specifically
with respect to their performance in identifying
pathogenic variants [37]. The results of these studies
suggest that each method has strengths and
weaknesses, possibly resulting from the data used
for development and the types of information(a) sketches the sequence and secondary structure
HUMAN, ID: P07550 [12]; assignment of secondary from
4]). For each of the 413 residues (x-axis) of the receptor, (b)
ts (y-axis; the stronger the predicted effect, the redder; the
fragment spanning from residue 91 to residue 210 and the
osed target residues (W99 and Y199). (d) The predicted
[15]); both known binding sites (positions 113 and 118) are
score ranges from the most neutral (−100) to the strongest
s “neutral” given the biophysical amino acid features as
ne regions and in the BLOSUM62 matrix [17] for all other
ge depicts intermediate scores (40 b score b 60), yellow
SNAP scores b20 (predicted as neutral or with little effect).
t and the two residues (W99 and Y199) that exhibit a high
traint (predicted by EVfold [18,19]) with each other and the
3940 Perspective: The Protein Mutability Landscapeincluded in prediction. Good in silico methods
correctly predict the experimentally observed effects
for most variants.
Typically, only 5–10% of all residues relate directly
to function [38–40]. Some of these are revealed in
the substitution profiles of protein families. A whole
generation of methods targets the prediction of such
functional sites through analyzing evolutionary infor-
mation (e.g., ET [41], INTREPID [42] or DISCERN
[43]). Since these methods predict functional sites, it
is not surprising that they also capture some of the
signal that variants impact function (V. Link and K.
Sjölander, unpublished results). Thus, the ability to
predict the functional effect of variants is clearly
related to predicting protein function.
Predictions of variant effects have helped us
prioritize mutations for large-scale reverse genetics
projects, where mutations are randomly introduced
into the genome. An example for such strategies is
TILLING (targeting induced local lesions in ge-
nomes), a method that combines chemical muta-
genesis with a sensitive DNA screening technique in
order to allow direct identification of mutations in a
specific gene. TILLING uses the functional effect
predictions from SIFT [22,23] to prioritize the
post-processing of variants [44]. Another important
application is to the assessment of disease-related
human variants [20,45,46]. For instance, mutations
that directly cause a disease, such as those found in
OMIM [47], are clearly identified by methods that
predict the functional effect of variants [48]. Existing
in silicomethods can even be good enough to reveal
problems with experimental data: today's assess-
ment of functional neutrality of variants seems
particularly problematic [100]Peeking Experimentally into the Protein
Mutability Landscape
Alanine scans reveal function and interaction
hot spots
The experimental study on how site-directed
mutagenesis affects phenotypes may be THE most
essential experimental tool for determining protein
function. By substituting residues that are assumed
to be important and measuring substitution effect,
researchers identify the residues that are important
for the hypothesized protein function. Over the last
decade, the power of experimental and computa-
tional mutagenesis has grown considerably: a
decade ago, many publications reported on single
point mutations; today, 50 times more may no longer
satisfy reviewers.
The ability of proteins to interact with substrates or
other proteins is essential. The most important
function of a protein can therefore be defined as itsrole within an interaction pathway [49]. Typically,
only a few residues in a protein interaction interface
contribute most of the binding affinity. These can be
identified by the change in binding free energy upon
mutation to alanine and are often referred to as
binding hot spots [50,51]. One definition for a hot
spot is that the binding free energy is altered by
≥1 kcal/mol upon mutation [52]. While the precise
definition might be subject to debate, hot spots are
“real” in the sense that they can be predicted
accurately by methods that do not even assume
that hot spots exist [53]. We moreover might
anticipate the observation that the residues or
positions contributing most to the energy of binding
might also be the residues used more frequently
when choosing sites that bind to many binding
partners. Indeed, hot spots have been observed to
have a high propensity for interaction with multiple
partners [54].
Substituting the native amino acid by alanine is
typically experimentally easiest and expected to be
most revealing. Thus, alanine scans are most
common, but increasingly, glycine, proline and
cysteine scans are also carried out [55–57]. In
these scans, all native residues of a protein are
individually substituted by one of the above amino
acids and the effect upon a given functional assay is
measured. ASEdb, the Alanine Scanning Energetics
database, provides a central repository for such data
[58]. Residues that significantly change protein
function are usually considered important. What
constitutes a significant change depends on the
type of function. In silico predictions suggest that
when looking at the effect of all 19-non-native
mutations, alanine substitutions are most represen-
tative (correlate most with the average over all
mutations) [21]. Although this observation is based
on one single protein (HXK4) and may therefore not
be representative, the fact that in silico methods
accurately reproduce such expert knowledge should
be appreciated as an independent evidence of their
success in predicting essential aspects of the
mutability landscape.
Mutability landscape constrained by correlation
networks?
Comprehensive experimental mutagenesis stud-
ies confirmed that the effect of point mutations
(SAAS) upon function depends crucially on their
positions in the protein sequence [59–61]. Even
within a unit as familiar as the DNA binding domain of
the Escherichia coli LacI [62,63] repressor, almost
any variant can be tolerated at some positions while,
at others, all variants affect function (Fig. 2a). Simple
structural constraints might suffice to explain this
variability: to accommodate the negatively charged
DNA, binding regions of the repressor contain
positively charged residues. Furthermore, binding
Fig. 2. Mutagenesis of E. coli LacI repressor. At each position between residue 2 and 329, 12–13 amino acid
substitutions are displayed as a bar. The height of a bar depicts the relative percentage of substitutions that alter the
repressor function as determined (a) experimentally [59] or (b) by computational prediction using SNAP2. With a
correlation of 0.76 over all residues and an accuracy of 78.2% over all variants, this constitutes a below-average prediction
of SNAP2 (~82% estimated overall accuracy).
3941Perspective: The Protein Mutability Landscaperequires helix formation. These two simple biophys-
ical realities constrain the mutability landscape
significantly in a specific, identity-revealing manner
like a fingerprint. The differential sensitivity to
mutation might just be a complex overlay of many
such simple biophysical constraints.
The same constraints are written into the profile
of evolutionary conservation of changes observed
within families of related proteins [64–66]. These
evolutionary imprints are strong enough to aid the
prediction of protein structure [67–70] and function
[39]. One particular idea that uses the constraints
imposed by the mutability landscape is that of
compensating/correlated mutations [71–73]. To
simplify this, imagine a salt bridge, that is, the
interaction between a positively charged residue
and a negatively charged residue. If the negative
one is mutated into a positively charged amino acid,
the affected protein may malfunction. A compensa-
tory mutation that also flips the charge of the
positive position will again allow salt-bridge forma-
tion. If we could identify correlated mutations, we
could use them to predict inter-residue contacts
within [72] and between proteins [74,75]. After
many years of development [18,76], this concept
has finally brought about de novo predictions for
three-dimensional (3D) structure of globular [77]
and large membrane proteins [18,19], several of
those are not similar to any protein structure we
know today. Such predictions may even lead the
way beyond structure [19]: many residues that are
evolutionarily coupled and not close in space may
be relevant for protein function. In fact, in a study of
over 14,000 variants related to disease from over
1000 human proteins, correlated positions
appeared significantly more likely to harbor disease
mutations than average positions [78]. Compensa-
tory mutations involve coupled variants and might
rashly be considered to go beyond the focus of this
review. We show that the correlated mutationsperfectly highlight the importance of analyzing the
mutability landscape.
Other recent studies carry the theme of coevol-
ving positions even further. Patterns of correlated
mutations in the WW domain nearly suffice to
synthetize artificial WW domains with native-like
folding and function [79,80]. Applying statistical
coupling analysis to the S1A protein family, the
Ranganathan laboratory introduced the “sector
hypothesis” [81] that proteins are organized into
distinct subunits or networks (sectors) of coevolving
residues that are essential to structure and function.
Such sectors involve only about every fifth residue;
they are built around active sites, and they connect
to other functional sites distant in sequence and
structure through “networks” of contiguous residue
interactions in the protein core [82]. These networks
of coevolving residues may have resulted from the
need for rapid adaptive variation arising from
fluctuating selection pressure and that the organi-
zation into networks of cooperatively acting resi-
dues may provide such rapid adaptive potential
through only a few mutations [82]. If so, structure
and function may mostly be affected by mutations at
sector positions while non-sector positions may
tolerate variation. This hypothesis was tested
through a complete single mutagenesis (individually
substituting each residue by all 19 non-native amino
acids) in one representative member of the PDZ
family (PSD95pdz3) [82]. The study showed that the
statistical correlation between mutations with signif-
icant functional effect and sector positions was very
strong; it was, in fact, stronger than that between
mutations in the protein core (buried positions) and
positions with ligand contacts. Moreover, a combi-
nation of two mutations at sector positions was
sufficient to change the binding specificity of
PSD95pdz3 for a class-switching ligand. This adap-
tion is exclusively initiated through mutations in the
sector. While awaiting large-scale confirmation,
3942 Perspective: The Protein Mutability Landscapethese findings already highlight the importance of
annotating correlated mutational behavior for the
prediction of pathogenicity/functional effects of
missense variants.Penetrating the Protein Mutability
Landscape In Silico
Predicting the mutability landscape of the
human exome
Ultimately, we want to study the entire protein
mutability landscapes for at least some hundreds of
representative proteins by assaying changes in
protein function and their impact upon the organism.
Despite tremendous breakthroughs in high-through-
put experimentation, this analysis falls more into the
world of Lewis Carroll than into that of a scientific
grant proposal. However, such a landscape can be
easily predicted, for example, for all human proteins.
The downside is that we do not yet fully understand
how to interpret the results. Nevertheless, in the
context of understanding the deep sequencing data,
such views are needed.
Finding the causal variants for a particular disease
continues to be a challenging endeavor despite the
continued decrease of the cost in sequencing entire
genomes and entire exomes [83]. Accordingly,
researches prioritize zooming in onto candidate
variants in these studies by including computational
effect predictions [84]. It has been suggested to
combine several prediction methods (e.g., through
majority vote) in order to overcome individual
weaknesses and obtain most reliable predictions
[85]. The dbNSFP [86] database is built to simplify
this endeavor by providing effect predictions and
scores from various methods for every potential
variant in the human genome (approximately 76
million variants). Differences between methods
become most apparent when comparing predictions
on this large scale. The pairwise agreement between
the four methods in dbNSFP ranges from 61% to
77%. The fraction of all potential substitutions
predicted to be deleterious by individual methods
ranges from 40% to 56%, suggesting that methods
disagree strongly. Overall, methods accurately
predict Mendelian disease-causing variants to
strongly effect function. Unfortunately, this does not
imply that the same methods can find a single
disease-causing variant among the thousands of
variants observed between any pair of individuals
from the same population.
To visualize the predictive behavior of the two
widely used methods SNAP [24,25] and SIFT
[22,23], we compiled a pairwise amino acid substi-
tution matrix over all theoretically possible variants in
the human proteome based on the predictions ofeach method (Fig. 3; note that not all of those
variants can be observed since not all amino acids
can be transformed into all others through a SNP).
Although SNAP predicts more effect substitutions
than SIFT, trends appear to be largely similar. For
instance, both methods predict substitutions from
and to tryptophan as highly damaging on average.
This is plausible due to its structural importance to
proteins. Similarly, both methods predict substitu-
tions of phenylalanine by any other residue, except
for leucine and tyrosine, as rather damaging.
Phenylalanine is preferentially exchanged with
tyrosine, which differs only in that it contains a
hydroxyl group in place of the ortho hydrogen on the
benzene ring. The preference for leucine seems
plausible due to its hydrophobic character. Exam-
ples of SNAP and SIFT differences are in the
predictions for substitutions of arginine and by
proline. SNAP might be closer to the truth for these
two because they may be difficult to treat via a purely
evolution based method. “To proline” mutations are
likely to be rare due to their disruptions. For arginine,
the explanation seems less clear. How can we cast
such predictions into new methods that, for example,
predict active sites? How can we use them to guide
protein design?
Outcome of alanine scans predicted
Methods that predict functional effects have rarely
been assessed in large-scale mutagenesis experi-
ments. One reason is obviously the shortage of such
experiments. Another might be the perception that
computational methods typically predict neither the
severity nor the direction of the effect (increase or
decrease of function/affinity). It is true that today's
prediction methods cannot directly distinguish be-
tween variants that increase and those that de-
crease binding. Instead, both tend to be predicted as
effects. Nevertheless, prediction scores (i.e., the
signal strength) on average correlate with the
severity of the effect [24]. The concept of “impor-
tance for function” never entered the data set choice
or development phase when creating SNAP. Still,
when applied for residues in ASEdb that the method
had never “seen” before, it correctly identified over
70% of the functionally important sites and correctly
predicted many to-alanine variants (up to 84%,
depending on cutoff) [21].
Comprehensive in silico mutagenesis helps
studying disease-related proteins
A detailed study of the human melanocortin 4
receptor (hMC4R) demonstrated the value of study-
ing the mutability landscape in silico [20]. hMC4R is
related to diabetes and to weight regulation. Muta-
tions in hMC4R have been shown to account for
approximately 3% of all severe obesity cases (body
Fig. 3. Effect of pairwise amino acid substitutions in the human exome. Shown is the fraction of substitutions predicted
to have an effect for every substitution of every amino acid (y-axis) by any other (x-axis) in the entire human exome.
Results were obtained by locally calculating the predictions for (a) SNAP and (b) SIFT for every possible SAAS in every
reviewed protein in the Swiss-Prot database [12] with human origin. Cells are colored according to the fraction of
deleterious predictions with high values in red and low values in white. For every prediction for substitutions of amino acid
“m” (y-axis) by “n” (x-axis), we applied the default threshold for each method (SNAP, 0; SIFT, 0.05).
3943Perspective: The Protein Mutability Landscapemass index, N40), and consequently, they are the
most frequent cause of monogenic obesity in
humans [87,88]. MC4R, a member of the G-pro-
tein-coupled receptor (GPCR) family, is an integral
membrane protein that crosses the lipid bilayer withseven transmembrane helices. SNAP assessed the
functional essentiality for each of the 332 residues in
hMC4R and the functional impact of all possible
variants; predictions were compared to all available
experimental data. The predictions of variants with
3944 Perspective: The Protein Mutability Landscapefunctional effect and predictions of important regions
in hMC4R largely agreed with experimental evi-
dence [20]. Toward this end, we down-weighted
mutations expected to be neutral for structure (e.g.,
hydrophobic to hydrophobic in membrane regions).
Despite this scoring, the computational mutagen-
esis predicted as many as 118 residues to be
functionally important. This seems a substantial
over-prediction. Indeed, so far, we have experimen-
tal evidence for only 18 residues to be important for
function; 15 of these 18 were in the set of 118
residues predicted to have strong impact [20], which
is not an impressive performance but much higher
than the random 6 in 18. The nsSNP database of
effects (SNPdbe [89]) provides experimental links to
obesity for 27 residues, 17 of those were in the 118.
Only one single residue is found in both sets. Thus,
in silico mutagenesis correctly predicted 31 of the
known 44 positions reported to influence function
if mutated.
What about the 74 residues with predictions but
without observation (118 predicted, 44 so far
experimentally known)? At this point, 74 mutations
constitute a relatively large number of high-effect
predictions, which cannot be verified due to lack of
data. Re-evaluating the predictions, we might
apply a more stringent threshold to consider an
effect important. For instance, at a threshold with
an expected accuracy N95%, 22 residues are
predicted to impact function; 10 of those corre-
spond to experimentally known sites, 1 corre-
sponds to a site implicated with obesity and 11
remain without experimental annotations. These
might constitute ideal starting points for designing
new experiments [20].
Detailed analysis of mutability landscape for a
GPCR, the beta-2-adrenergic receptor
To visualize the results of such an in silico
mutagenesis, we applied SNAP2 (M.H., unpublished
results) to another GPCR, the beta-2 adrenergic
receptor for which experimental high-resolution 3D
structures are available in the Protein Data Bank
(PDB) [90] (PDB ID: 2RH1 [15], Fig. 1d; PDB ID:
3PDS [13], Fig. 1e). The predicted high-effect
regions cluster around the binding sites and are
significantly more abundant on the inside (facing the
binding sites) than elsewhere. Strong effects
(SNAP N 60; note: score ranges [−100,+100]) are
predicted for 57 residues (Fig. 1d, red highlighting)
including the two Swiss-Prot annotated [12,91]
binding sites D113 and T118. Nine more sites with
functional effect annotation in SNPdbe [89] were
found. Among these, we find (1) D79, for which a
mutation to N was shown to affect binding of
catecholamines and to produce an uncoupling
between the receptor and stimulatory G-proteins
[92,93], and (2) D130, for which mutations to A or Nwere shown to increase pindolol-stimulated cAMP
accumulation [94,95]. Although located in the cyto-
plasmic region, strong signals also highlight (1)
Y141, for which a substitution by F is known to
abolish insulin-induced tyrosine phosphorylation and
insulin-induced receptor super sensitization [96],
and (2) C341, for which a mutation to G was
shown to alter binding (uncoupling of receptor) [97].
Thus, 46 sites (57 predicted, 11 experimentally
observed) remain with strong effect predictions for
which no variants have been tested experimentally.
Again we observe a rather large discrepancy
between observed and predicted “sensitive to
mutation” positions. Some of these predictions will
likely just be false positives. However, due to being
located in the protein core, others may in fact affect
function by structural alterations/misfolding. Applica-
tion of an even more stringent threshold (score N 80
at N95% expected accuracy) weeds out 38 of these,
leaving 12 residues with very strong effect pre-
dictions and without current variant annotations. We
studied these also in light of EVfold [18,19] (predic-
tion of inter-residue contacts through correlated
mutations). Only 2 of the 12 had residue couplings
in the realm of the top 5%, namely, W99 and Y199
(Fig. 1e). We could not find any experimental
annotation about these two. However, a visual
inspection (Fig. 1e) of a 3D structure with irreversibly
bound agonist (PDB ID: 3PDS [13]) appears to
suggest the two as reasonable targets for experi-
mental verification.
This detailed view of the beta-2-adrenergic recep-
tor provides another example for how useful it might
be to analyze the mutability landscape through a
complete in silico mutagenesis; it highlights func-
tionally important regions and may help in experi-
ment design to probe function locally or test entire
regions for docking and drug development. The
example also suggests that variant effect prediction
might benefit from including inter-residue contact/
evolutionary coupling predictions.Perspective
Comprehensive mutagenesis experiments have
furthered our understanding of protein function and
continue to provide insight into the mechanisms of
pathogenicity and adaption. Novel methodologies
and technical advancements reduce the cost of
experimental mutagenesis and enable research that
was previously impossible. Still, studying the coop-
erative behavior of amino acids and the combined
effect of mutations will remain a laborious and costly
task. This is where computational methods are
useful to predict the effects of variants upon protein
function, structure and pathogenicity. These
methods have grown in accuracy both in predicting
functional effect (Fig. 2b) and disease-causing
3945Perspective: The Protein Mutability Landscapemutations. Can they reach the next level? Can they
be used to study the mutability landscape of a
protein, that is, to unravel the effects of all possible
variants? Here, we argue that the study of such a
mutability landscape provides immensely important
value and that currently neither experimental nor
computational methods completely mine the poten-
tial of studying this landscape. Experimental
methods remain constrained by the substantial
amount of resources such studies would consume.
Computational methods remain constrained by the
degree to which we can interpret their results. At this
point, lack of comprehensive experimental data
seems a crucial problem for the development of
better computational tools. However, in silico ana-
lyses of mutability landscape already help to design
experiments and are crucial for the intelligent
interpretation of deep sequencing/next generation
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